Beatrice Bih Muma , NP
Nurse Practitioner • Hanover, MD
7580 Buckingham Blvd Ste 110
Hanover, MD 210763208
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 17, 2018; this date does not establish years in practice.
-
Published CMS data list 39,023 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J3145 — Injection, testosterone undecanoate, 1 mg: 28,500 service units.
- J0897 — Injection, denosumab, 1 mg: 3,840 service units.
- J9030 — Bcg live intravesical instillation, 1 mg: 2,600 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 24 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,212 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Alfuzosin Hcl Er (Alfuzosin Hcl) — 286 prescription fills, including refills.
- Tamsulosin Hcl — 232 prescription fills, including refills.
- Finasteride — 166 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 20 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Nurse Practitioner in Maryland (2024, 493 clinicians with data). Median for this group: 393. Middle half: 151 to 930.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 568 in 2020 to 39,023 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
7580 Buckingham Blvd Ste 110
Hanover, MD 210763208
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Chesapeake Urology Associates Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2018
What Public CMS Data Show
Nurse Practitioner: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
772 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $360,350 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $277,335 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,660 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$590,575 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,148.73 across 98 records.
By nature of payment
- Food and Beverage: $2,138.83 across 97 records.
- Education: $9.90 across 1 record.
Reporting-company totals (3 largest of 28)
- Bayer Healthcare Pharmaceuticals Inc.: $288.80 across 10 records.
- Sumitomo Pharma America, Inc.: $235.13 across 11 records.
- Ferring Pharmaceuticals Inc.: $205.56 across 14 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
8 years (graduated 2018)
CMS Doctors and Clinicians data list 2018 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2018
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Beatrice Muma has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Beatrice Muma as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Hanover and Maryland
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Nurse Practitioner in Maryland (2024, 493 clinicians with data). Median for this group: 393. Middle half: 151 to 930.
Too few clinicians listed under Nurse Practitioner in Hanover have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Nurse Practitioner in Maryland (2024, 493 clinicians with data). Median for this group: $31,922. Middle half: $12,534 to $67,404.
Too few clinicians listed under Nurse Practitioner in Hanover have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Nurse Practitioner in Maryland (2024, 493 clinicians with data). Median for this group: $24,077. Middle half: $9,239 to $51,413.
Too few clinicians listed under Nurse Practitioner in Hanover have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Nurse Practitioner in Maryland (2024, 506 clinicians with data). Median for this group: 317. Middle half: 87 to 1,029.
Too few clinicians listed under Nurse Practitioner in Hanover have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Nurse Practitioner in Maryland (2024, 506 clinicians with data). Median for this group: $27,195. Middle half: $2,059 to $147,767.
Too few clinicians listed under Nurse Practitioner in Hanover have Medicare Part D data for 2024 to compare.
9 active clinicians are listed under Nurse Practitioner with a practice address in Hanover, MD (1,273 in Maryland).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 6770% from 568 in 2020 to 39,023 in 2024.
- 2020: 568
- 2021: 4,395
- 2022: 6,022
- 2023: 9,805
- 2024: 39,023
-
Medicare-allowed amount
Medicare-allowed amount increased 1263% from $26,433 in 2020 to $360,350 in 2024.
- 2020: $26,433
- 2021: $90,147
- 2022: $174,613
- 2023: $278,197
- 2024: $360,350
-
Paid by Medicare
Paid by Medicare increased 1378% from $18,758 in 2020 to $277,335 in 2024.
- 2020: $18,758
- 2021: $70,182
- 2022: $134,137
- 2023: $211,362
- 2024: $277,335
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 316% from 291 in 2020 to 1,212 in 2024.
- 2020: 291
- 2021: 513
- 2022: 632
- 2023: 1,022
- 2024: 1,212
-
30-day fills
30-day fills increased 479% from 459 in 2020 to 2,660 in 2024.
- 2020: 459
- 2021: 924
- 2022: 1,245
- 2023: 2,143
- 2024: 2,660
-
Part D drug cost
Part D drug cost increased 2922% from $19,541 in 2020 to $590,575 in 2024.
- 2020: $19,541
- 2021: $32,625
- 2022: $204,447
- 2023: $408,024
- 2024: $590,575
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 16% from $1,849.58 in 2021 to $2,148.73 in 2025.
- 2021: $1,849.58
- 2022: $1,873.51
- 2023: $2,209.26
- 2024: $2,130.18
- 2025: $2,148.73
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 98 records totaling $2,148.73.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| IMMUNITYBIO, INC. |
Food and Beverage
In-kind items and services
|
ANKTIVA | General | $135.17 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $64.78 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $33.10 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
SpaceOAR VUE System - 10mL | General | $30.51 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $29.85 |
| Caris MPI, Inc. |
Food and Beverage
In-kind items and services
|
MI CANCER SEEK | General | $29.03 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $28.96 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $28.81 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
YONSA | General | $28.10 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $28.01 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $27.60 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $27.51 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $27.45 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
JATENZO | General | $27.44 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $27.42 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $27.12 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $26.99 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $26.99 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $26.85 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $26.27 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $26.06 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $26.01 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $25.82 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $25.55 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $25.36 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2019–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J3145
Injection, testosterone undecanoate, 1 mg
|
28,500 | 12 | $3.00 | $1.80 |
|
J0897
Injection, denosumab, 1 mg
|
3,840 | 21 | $35.77 | $25.61 |
|
J9030
Bcg live intravesical instillation, 1 mg
|
2,600 | 20 | $5.00 | $2.59 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
726 | 587 | $42.73 | $14.34 |
|
81003
Automated urinalysis test
|
620 | 475 | $5.00 | $2.15 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
473 | 372 | $305.47 | $112.11 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
308 | 42 | $168.25 | $55.48 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
307 | 246 | $61.71 | $11.85 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
294 | 31 | $432.53 | $175.14 |
|
36415
Insertion of needle into vein for collection of blood sample
|
249 | 196 | $21.00 | $8.65 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
222 | 199 | $269.58 | $79.99 |
|
J9201
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
|
165 | 13 | $53.61 | $3.25 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
143 | 143 | $264.25 | $97.99 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
106 | 33 | $128.15 | $42.54 |
|
51720
Instillation of anti-cancer drug into bladder
|
85 | 32 | $395.46 | $75.50 |
|
96372
Injection of drug or substance under skin or into muscle
|
80 | 34 | $115.55 | $12.62 |
|
99426
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
|
68 | 14 | $165.51 | $54.96 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
64 | 37 | $142.39 | $31.27 |
|
51702
Simple insertion of temporary bladder tube
|
62 | 25 | $147.08 | $55.91 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
29 | 29 | $404.69 | $148.15 |
|
51703
Complicated insertion of bladder tube
|
27 | 14 | $310.11 | $129.58 |
|
51705
Simple change of bladder tube
|
26 | 11 | $218.08 | $87.60 |
|
51700
Simple bladder irrigation and/or instillation
|
17 | 11 | $172.12 | $68.76 |
|
51741
Electronic assessment of bladder emptying
|
12 | 11 | $197.67 | $11.77 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Alfuzosin Hcl Er | Alfuzosin Hcl | 286 | 21,982 | $8,256.21 | 108 |
| Tamsulosin Hcl | Tamsulosin Hcl | 232 | 17,969 | $4,602.70 | 73 |
| Finasteride | Finasteride | 166 | 14,395 | $2,613.33 | 60 |
| Myrbetriq | Mirabegron | 77 | 3,750 | $55,070.26 | 21 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 53 | 833 | $286.01 | 46 |
| Gemtesa | Vibegron | 48 | 1,980 | $30,329.01 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 46 | 411 | $332.54 | 42 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 42 | 3,095 | $1,102.27 | 18 |
| Estradiol | Estradiol | 31 | 1,752 | $2,164.85 | 16 |
| Xtandi | Enzalutamide | 31 | 990 | $461,624.89 | — |
| Potassium Citrate Er | Potassium Citrate | 29 | 1,250 | $2,602.43 | — |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 584 | $576.14 | 23 |
| Premarin | Estrogens, Conjugated | 27 | 1,396 | $11,826.54 | 16 |
| Prednisone | Prednisone | 25 | 801 | $121.87 | — |
| Solifenacin Succinate | Solifenacin Succinate | 23 | 1,355 | $2,393.49 | — |
| Silodosin | Silodosin | 20 | 1,680 | $1,831.72 | — |
| Methenamine Hippurate | Methenamine Hippurate | 13 | 570 | $853.98 | — |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | 450 | $1,012.18 | — |
| Tadalafil | Tadalafil | 12 | 1,080 | $806.64 | — |
| Testosterone | Testosterone | 11 | 750 | $2,167.74 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-05-30NUCC Taxonomy Code: 363L00000X
(1) A registered nurse provider with a graduate degree in nursing prepared for advanced practice involving independent and interdependent decision making and direct accountability for clinical judgment across the health care continuum or in a certified specialty. (2) A registered nurse who has completed additional training beyond basic nursing education and who provides primary health care services in accordance with state nurse practice laws or statutes. Tasks performed by nurse practitioners vary with practice requirements mandated by geographic, political, economic, and social factors. Nurse practitioner specialists include, but are not limited to, family nurse practitioners, gerontological nurse practitioners, pediatric nurse practitioners, obstetric-gynecologic nurse practitioners, and school nurse practitioners.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NURSE PRACTITIONER
I20190228002410
MD
8729327184
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Chesapeake Urology Associates Llc
10710 Charter Dr, Columbia, MD 210443258
Phone: 4107727000
Chesapeake Urology Associates Llc
1838 Greene Tree Rd, Baltimore, MD 212087113
Phone: 4105818140
Chesapeake Urology Associates Llc
3801 International Dr, Silver Spring, MD 209061550
Phone: 3015989171
Chesapeake Urology Associates Llc
6535 N Charles St, Baltimore, MD 212045835
Phone: 4108255454
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Physician Assistant - Surgical
Physician Assistant (Certified)
Urology
Doctor of Medicine (M.D.)
Physician Assistant - Surgical
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 10200 GRAND CENTRAL AVE STE 220, OWINGS MILLS, MD 211174366 (Tel: 4105811600)
Registered at 7580 BUCKINGHAM BLVD STE 110, HANOVER, MD 210763208 (Tel: 4105811600)
Recorded as BEATRICE MUMA, NP
Nurse Practitioner (license number reported to NPPES: MD R178387)
NPI status registered as active in NPPES database
Registered at 7534 ROXY DR, WINDSOR MILL, MD 212442063 (Tel: 4438583602)
Registered at 7534 ROXY DR, WINDSOR MILL, MD 212442063 (Tel: 4438583602)
Recorded as BEATRICE MUMA, FNP
Nurse Practitioner (license number reported to NPPES: MD F178387)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Nurse Practitioners in Hanover
Mailing Address
10200 Grand Central Ave Ste 220
Owings Mills, MD 211174366
Phone: 4105811600